Bevacizumab in first-line therapy in lung metastases of colorectal cancer: An ARCAD pooled analysis Meeting Abstract
| Authors: | Shmueli, E. S.; Raeisi, M.; Chibaudel, B.; Hurwitz, H.; Saltz, L. B.; Kabbinavar, F. F.; Tebbutt, N. C.; Grothey, A.; Adams, R.; Zalcberg, J. R.; Yoshino, T.; Bachet, J. B.; Cohen, R.; Sharara, L.; Andre, T.; Shi, Q.; De Gramont, A. |
| Abstract Title: | Bevacizumab in first-line therapy in lung metastases of colorectal cancer: An ARCAD pooled analysis |
| Meeting Title: | 2023 ASCO Gastrointestinal Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 41 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2023 Jan 19-21 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2023-02-01 |
| Language: | English |
| DOI: | 10.1200/JCO.2023.41.4_suppl.118 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl |
| DOI/URL: | |
| Notes: | Meeting Abstract: 118 -- Accession Number: 161484591 -- Entry Date: In Process -- Revision Date: 20230127 -- Publication Type: Article -- Supplement Title: 2/1/2023 Supplement 1 -- Journal Subset: Biomedical; Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed; USA -- NLM UID: 8309333. -- Source: Cinahl |
